One of the WHO’s most important jobs is managing viral outbreaks. The rapid spread of mpox, a disease related to smallpox, is a reminder of its shortcomings.
Although well-intended, the WHO’s overcautious and convoluted regulatory process stalled vaccine delivery for months before an approval was granted last month. Hundreds of lives were lost in the meantime, many of them children.
Mpox, previously called monkeypox, was first discovered in monkeys used for research in 1958. The virus began circulating among humans in western and central Africa more than a decade later. This year, more than 27,000 suspected cases and 800 deaths have been reported in the Democratic Republic of the Congo (DR Congo). A serious outbreak in 2022, which began in Europe and spread to the US, largely subsided last year, although mpox never stopped circulating in the DR Congo.
A new, deadlier and more virulent version of mpox was discovered last year. Like past outbreaks, its symptoms are flu-like and include a rash that can develop into pustules or lesions that cover the body. When these excruciating sores erupt in the mouth and throat, eating can become difficult; some children have died of starvation as a result. Children under 15 make up two-thirds of cases and more than 80 percent of deaths in Africa.
A perfect storm of factors has accelerated the spread of mpox in the DR Congo. Ongoing political violence has displaced millions of people, who have crowded into camps where close contact is difficult to avoid and sex work is common.
Although mpox can spread via sexual contact, it is not considered a sexually transmitted disease.
The country is also battling cholera, malaria and measles.
Public health resources are understandably stretched. Yet the best means of fighting mpox — a safe and effective vaccine, approved by US and European regulators — has been available for years. Why did the WHO take so long to grant its approval and was its separate endorsement necessary?
Low and middle-income countries such as the DR Congo typically depend on UNICEF and global vaccine alliance Gavi to buy and distribute vaccines. Before doing so, the groups must have approval from the WHO, which can either “prequalify” the vaccines — by conducting its own data assessments, inspections and testing — or issue a so-called emergency use listing that would speed access to unlicensed products.
For two years, the WHO took neither path. Despite Congolese officials regularly sharing data with the WHO — and reports that Bavarian Nordic AS, the principal manufacturer, had submitted the research used for its European approval — the organization said it did not have the data required for prequalification.
Meanwhile, an emergency use listing could not be sought until an emergency had been formally declared, which did not happen until August.
Bavarian Nordic, for its part, was left in the dark about procurement commitments from Gavi, which awaited WHO authorization to begin purchase negotiations.
This nest of interdependent approvals would be maddening enough, even if the delays it caused were not so tragic.
The WHO’s instinct to review new data is to some extent understandable. Absent randomized clinical trials, it is hard to assess whether the vaccines approved in Europe and the US are effective against the version of the virus circulating in the DR Congo.
Moreover, giving an unauthorized vaccine to an otherwise healthy population, including children, can be risky. Yet as the virus spreads and the death toll mounts, the benefits of vaccination start to outweigh the potential costs — and the prospect of stalling to replicate lengthy regulatory processes becomes increasingly indefensible.
To its credit, the WHO has stepped up its response over the past month. Vaccine donations from rich countries have started to arrive and, with last month’s announcement, so, too, would purchases from Bavarian Nordic.
Yet the belated resolution must not obscure the need for a nimbler, more straightforward emergency approval process that allows for quick adoption of US and European standards without all the hoops. A similar process has been used successfully for years in Pepfar, the US government program to treat HIV, and should be expanded — if only for the next outbreak. More transparency with manufacturers and other stakeholders throughout the prequalification process would help, too.
The WHO has substantial responsibilities and it should not waste precious time duplicating efforts. By trusting its global partners, it can focus instead on saving lives.
The Editorial Board publishes the views of the editors across a range of national and global affairs.
The Chinese Nationalist Party (KMT) caucus in the Legislative Yuan has made an internal decision to freeze NT$1.8 billion (US$54.7 million) of the indigenous submarine project’s NT$2 billion budget. This means that up to 90 percent of the budget cannot be utilized. It would only be accessible if the legislature agrees to lift the freeze sometime in the future. However, for Taiwan to construct its own submarines, it must rely on foreign support for several key pieces of equipment and technology. These foreign supporters would also be forced to endure significant pressure, infiltration and influence from Beijing. In other words,
As Taiwan’s domestic political crisis deepens, the opposition Chinese Nationalist Party (KMT) and Taiwan People’s Party (TPP) have proposed gutting the country’s national spending, with steep cuts to the critical foreign and defense ministries. While the blue-white coalition alleges that it is merely responding to voters’ concerns about corruption and mismanagement, of which there certainly has been plenty under Democratic Progressive Party (DPP) and KMT-led governments, the rationales for their proposed spending cuts lay bare the incoherent foreign policy of the KMT-led coalition. Introduced on the eve of US President Donald Trump’s inauguration, the KMT’s proposed budget is a terrible opening
“I compare the Communist Party to my mother,” sings a student at a boarding school in a Tibetan region of China’s Qinghai province. “If faith has a color,” others at a different school sing, “it would surely be Chinese red.” In a major story for the New York Times this month, Chris Buckley wrote about the forced placement of hundreds of thousands of Tibetan children in boarding schools, where many suffer physical and psychological abuse. Separating these children from their families, the Chinese Communist Party (CCP) aims to substitute itself for their parents and for their religion. Buckley’s reporting is
Last week, the Chinese Nationalist Party (KMT) and the Taiwan People’s Party (TPP), together holding more than half of the legislative seats, cut about NT$94 billion (US$2.85 billion) from the yearly budget. The cuts include 60 percent of the government’s advertising budget, 10 percent of administrative expenses, 3 percent of the military budget, and 60 percent of the international travel, overseas education and training allowances. In addition, the two parties have proposed freezing the budgets of many ministries and departments, including NT$1.8 billion from the Ministry of National Defense’s Indigenous Defense Submarine program — 90 percent of the program’s proposed
RSS